Image 3-VILTEPSO (viltolarsen) - Clinical Trials Arena
Join Our Newsletter - Get important industry news and analysis sent to your inbox – sign up to our e-Newsletter here

VILTEPSO (viltolarsen) for the Treatment of Duchenne Muscular Dystrophy (DMD)

Image 3-VILTEPSO (viltolarsen)
DMD is caused by a DMD gene mutation, resulting in the lack of dystrophin muscle protein. Credit: StudioMolekuul / Shutterstock.